AWK vs MBRX · P/E 22, rev $4.65B vs $8.2M cap
American Water Works (AWK) versus Moleculin Biotech Inc (MBRX) — a side-by-side from cached financials, not a winner call.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Moleculin Biotech Inc (MBRX) is a biotechnology company listed on US.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Latest reported MBRX revenue for 2024-12-31 was $0. Net income was -$21.8M. MBRX currently screens at market cap $8.2M.
AWK currently screens at market cap $24.31B and trailing P/E 22.1. MBRX currently screens at market cap $8.2M.
Not investment advice. Open the AWK and MBRX stock pages for the full models.
Not investment advice.